Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26886556 |
JP |
8 | 2 |
Atrial fibrillation, Ejection fraction decreased, Hypersensitivity, Cardiac failure, |
||||
MAVACAMTEN, |
||||
| 502 | 26886561 |
US |
2 | |
Product packaging issue, Hypersensitivity, |
||||
TIOTROPIUM BROMIDE AND OLODATEROL, |
||||
| 503 | 26889358 |
75 | 1 | |
Vomiting, Hypersensitivity, Intentional dose omission, Rhinorrhoea, Eye inflammation, Photosensitivity reaction, Visual impairment, |
||||
SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE, ATORVASTATIN CALCIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, |
||||
| 504 | 26890396 |
59 | ||
Arthralgia, Peripheral swelling, Musculoskeletal stiffness, Pain in extremity, Burning sensation, Paraesthesia, Myalgia, Hypersensitivity, Weight decreased, Oral discomfort, Paraesthesia oral, Taste disorder, |
||||
GABAPENTIN, |
||||
| 505 | 26876328 |
US |
2 | |
Hypersensitivity, |
||||
ORFORGLIPRON, |
||||
| 506 | 26876429 |
US |
54 | 2 |
Hypersensitivity, Arthropod sting, Throat tightness, Swelling face, Nasal congestion, |
||||
DUPILUMAB, |
||||
| 507 | 26876499 |
US |
2 | |
Hypersensitivity, |
||||
| 508 | 26876666 |
US |
2 | |
Hot flush, Cough, Throat irritation, Neuralgia, Cold flash, Eczema, Hypersensitivity, |
||||
SARILUMAB, CEFADROXIL, CICLOPIROX, CYANOCOBALAMIN, FAMOTIDINE, FOLIC ACID, GABAPENTIN, GABAPENTIN, HYDROCHLOROTHIAZIDE, IRBESARTAN, LEFLUNOMIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MELOXICAM, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, ROSUVASTATIN CALCIUM, |
||||
| 509 | 26877070 |
CA |
||
Drug hypersensitivity, Hypersensitivity, Rash, Off label use, |
||||
BENDAMUSTINE HCL, BENDAMUSTINE HCL, RITUXIMAB, RITUXIMAB, |
||||
| 510 | 26877136 |
US |
35 | |
Hypersensitivity, |
||||
EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, EPTINEZUMAB-JJMR, |
||||
| 511 | 26877216 |
US |
||
Hypersensitivity, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 512 | 26877416 |
US |
2 | |
Hypersensitivity, |
||||
LISINOPRIL, DUPILUMAB, DUPILUMAB, GABAPENTIN, |
||||
| 513 | 26877520 |
EU |
1 | 2 |
Thrombocytopenia, Rash, Hypersensitivity, Lividity, Ecchymosis, |
||||
| 514 | 26877770 |
US |
84 | |
Oxygen saturation decreased, Peripheral swelling, Therapy non-responder, Rhinorrhoea, Fatigue, Oxygen consumption increased, Dyspnoea exertional, General physical health deterioration, Weight fluctuation, Hypersensitivity, Flushing, Headache, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, |
||||
| 515 | 26877775 |
US |
65 | |
Muscle rupture, Fall, Intervertebral disc protrusion, Pneumonia, Gait disturbance, Product residue present, Abdominal discomfort, Ear infection, Dry mouth, Product administration error, Illness, Headache, Cough, Diarrhoea, Nausea, Throat irritation, Hypersensitivity, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, DULOXETINE HYDROCHLORIDE, DULOXETINE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MENTHOL, CAMPHOR, CAPSAICIN, MENTHOL, MENTHOL, UNSPECIFIED FORM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, POLYETHYLENE GLYCOL 3350, BUMETANIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ALLOPURINOL, FLUTICASONE PROPIONATE, BUPROPION HYDROCHLORIDE, COLCHICINE, SPIRONOLACTONE, WARFARIN SODIUM, WARFARIN, TIZANIDINE HYDROCHLORIDE, VITAMIN C, CETIRIZINE HYDROCHLORIDE, MAGNESIUM, METOLAZONE, |
||||
| 516 | 26877777 |
US |
83 | |
Choking sensation, Sinus congestion, Dry mouth, Rhinorrhoea, Pain, Sneezing, Wheezing, Dyspnoea exertional, Seasonal allergy, Hypersensitivity, Dyspnoea, Cough, Throat irritation, Headache, Diarrhoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, IPRATROPIUM BROMIDE, ALBUTEROL SULFATE, ERGOCALCIFEROL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, FLUOROMETHOLONE, DUPILUMAB, OXYGEN, 0XYGEN, QUININE SULFATE, QUININE, HYOSCYAMINE SULFATE, CYCLOSPORINE, BENZONATATE, |
||||
| 517 | 26877793 |
US |
1 | |
Pruritus, Skin ulcer, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 518 | 26877827 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 519 | 26877851 |
CA |
40 | 2 |
Vomiting, Liver function test increased, Confusional state, Mobility decreased, Swelling, Back injury, Drug hypersensitivity, Nausea, Hypertension, Gastrooesophageal reflux disease, Osteoarthritis, Folliculitis, Glossodynia, Onychomadesis, Abdominal distension, Hand deformity, Dyspepsia, Hypersensitivity, Dyspnoea, Fall, Product label confusion, |
||||
LAMOTRIGINE, LEFLUNOMIDE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CELECOXIB, CELECOXIB, OXYCODONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, INFLIXIMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, MAGNESIUM HYDROXIDE, ADALIMUMAB, ADALIMUMAB, CANDESARTAN, SARILUMAB, SARILUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ETANERCEPT, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, METHYLPREDNISOLONE, SECUKINUMAB, |
||||
| 520 | 26878105 |
EU |
29 | 2 |
Acute respiratory distress syndrome, Contraindicated product administered, Tachycardia, Hypertension, Hypersensitivity, |
||||
KETOPROFEN, |
||||
| 521 | 26878363 |
IN |
1 | |
Mantle cell lymphoma recurrent, Hypersensitivity, |
||||
RITUXIMAB, |
||||
| 522 | 26878515 |
CN |
||
Off label use, White blood cell count decreased, Neutropenia, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood creatinine increased, Hypofibrinogenaemia, Activated partial thromboplastin time shortened, High density lipoprotein increased, Hypersensitivity, Liver abscess, Menstrual disorder, Gastrointestinal disorder, |
||||
TOCILIZUMAB, |
||||
| 523 | 26878685 |
EU |
62 | 2 |
Hypersensitivity, Eye irritation, Lacrimation increased, Periorbital irritation, Alopecia, Madarosis, Onychomadesis, Cutaneous symptom, Sensory loss, Neuropathy peripheral, Arthropathy, Cardiac failure, Liver function test increased, Taste disorder, Depression, Skin irritation, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LETROZOLE, LETROZOLE TABLETS, |
||||
| 524 | 26879127 |
EU |
52 | 1 |
Infantile spasms, Hypersensitivity, |
||||
GLATIRAMER, GLATIRAMER, GLATIRAMER, GLATIRAMER, |
||||
| 525 | 26879250 |
US |
60 | |
Abdominal discomfort, Gastrooesophageal reflux disease, Sinusitis, Cough, Diarrhoea, Oropharyngeal pain, Hypersensitivity, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, PREDNISONE, FUROSEMIDE, MONTELUKAST SODIUM, EMPAGLIFLOZIN, ALBUTEROL SULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, FAMOTIDINE, OXYGEN, 0XYGEN, SPIRONOLACTONE, TIRZEPATIDE, FERROUS SULFATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, |
||||
| 526 | 26879254 |
91 | 2 | |
Hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 527 | 26879842 |
US |
51 | 2 |
Swelling face, Hypersensitivity, Urinary retention, |
||||
ARIMOCLOMOL CITRATE, |
||||
| 528 | 26879860 |
GB |
81 | 1 |
Urosepsis, Fungal infection, Hypersensitivity, |
||||
DAPAGLIFLOZIN, LANSOPRAZOLE, BISOPROLOL FUMARATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 529 | 26879863 |
CN |
||
Anaphylactic shock, Liver injury, Blood disorder, Intestinal obstruction, Urinary retention, Tardive dyskinesia, Hypertonia, Tremor, Eye movement disorder, Dizziness, Asthenia, Anxiety, Akathisia, Feeling jittery, Drooling, Vision blurred, Headache, Facial pain, Tremor, Bradykinesia, Salivary hypersecretion, Mental disorder, Dysphoria, Poor quality sleep, Hypoaesthesia oral, Musculoskeletal stiffness, Stiff tongue, Dyskinesia, Chest discomfort, Torticollis, Dysarthria, Photophobia, Eye pain, Lacrimation increased, Rash, Pruritus, Hypersensitivity, Purpura, Rash maculo-papular, Skin burning sensation, Constipation, Vomiting, Abdominal distension, Decreased appetite, Hepatic function abnormal, Nausea, Diarrhoea, Hepatic enzyme increased, Hepatic function abnormal, Oedema peripheral, Oedema peripheral, Oedema, Joint swelling, Face oedema, Oedema peripheral, Eyelid oedema, Tachycardia, Palpitations, Heart rate increased, Bradycardia, Hyperlipidaemia, Blood pressure fluctuation, Amenorrhoea, Amenorrhoea, Hyperglycaemia, Obesity, Weight increased, White blood cell count decreased, Full blood count decreased, Dysuria, Priapism, Extrapyramidal disorder, Hypotension, Gastrointestinal disorder, Dermatitis allergic, Menstruation irregular, |
||||
RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, RISPERIDONE, HALOPERIDOL, HALOPERIDOL LACTATE, QUETIAPINE, ZIPRASIDONE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 530 | 26879884 |
US |
||
Hypersensitivity, |
||||
AMLODIPINE BESYLATE, |
||||
| 531 | 26879929 |
US |
72 | |
Oxygen saturation decreased, Fatigue, Product use issue, Apathy, Anxiety, Asthenia, Bradycardia, Dyspnoea, Dizziness, Hypersensitivity, Headache, Throat irritation, Cough, Hypotension, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, CARVEDILOL, IBANDRONATE SODIUM, POTASSIUM CHLORIDE, ALLOPURINOL, AZELASTINE HYDROCHLORIDE, AZELASTINE, LOSARTAN POTASSIUM, LOSARTAN, PANTOPRAZOLE SODIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OXYGEN, 0XYGEN, CHLORTHALIDONE, AMLODIPINE BESYLATE, ERGOCALCIFEROL, |
||||
| 532 | 26879934 |
US |
2 | |
Rash, Urticaria, Pruritus, Hypersensitivity, |
||||
DUPILUMAB, TIRZEPATIDE, ROSUVASTATIN, |
||||
| 533 | 26880259 |
70 | 2 | |
Hypersensitivity, Condition aggravated, Eye irritation, Eye pain, Lacrimation increased, Vision blurred, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 534 | 26880290 |
US |
55 | 2 |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 535 | 26880389 |
US |
26 | 2 |
Hypersensitivity, Fatigue, |
||||
NATALIZUMAB, |
||||
| 536 | 26880425 |
US |
2 | |
Hypersensitivity, Multiple sclerosis, |
||||
NATALIZUMAB, NATALIZUMAB, |
||||
| 537 | 26880726 |
US |
54 | 2 |
Hypersensitivity, |
||||
LETIBOTULINUMTOXINA-WLBG, |
||||
| 538 | 26880961 |
US |
11 | 2 |
Hypersensitivity, |
||||
CALASPARGASE PEGOL, |
||||
| 539 | 26881215 |
US |
2 | |
Rash pruritic, Vomiting, Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 540 | 26884774 |
40 | 1 | |
Urticaria, Hypersensitivity, |
||||
CETIRIZINE HYDROCHLORIDE, PREGABALIN, LOSARTAN, BUPROPION HYDROCHLORIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 541 | 26875210 |
US |
||
Hypersensitivity, Feeling abnormal, |
||||
CLONAZEPAM, |
||||
| 542 | 26875290 |
US |
79 | 2 |
Hypersensitivity, |
||||
MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 543 | 26875359 |
US |
65 | 2 |
Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 544 | 26875483 |
CA |
||
Food allergy, Hepatic enzyme increased, Joint swelling, Immunodeficiency, Hypertension, Hypersensitivity, Hyperhidrosis, Headache, Infusion related reaction, Pain, Exposure during pregnancy, Intentional product misuse, Overdose, Prescribed overdose, Off label use, Product use issue, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ABACAVIR SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, BUPROPION, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE, CLONIDINE HYDROCHLORIDE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ETANERCEPT, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FLUCONAZOLE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FUROSEMIDE, GABAPENTIN, GABAPENTIN, ADALIMUMAB, ADALIMUMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNA LEAF, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, TEMAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 545 | 26875541 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 546 | 26875650 |
US |
59 | 2 |
Hordeolum, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 547 | 26875842 |
US |
53 | 2 |
Psoriatic arthropathy, Stress, Malaise, Hypersensitivity, Incorrect dose administered by device, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 548 | 26875955 |
EU |
||
Hepatotoxicity, Pancreatitis, Pneumonitis, Lupus-like syndrome, Multiple sclerosis, Thyroid cancer, Psoriasis, Alopecia, Off label use, Hypersensitivity, Herpes zoster, Treatment failure, |
||||
INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 549 | 26872959 |
CA |
1 | |
Arthralgia, Arthritis, Peripheral swelling, Pulmonary oedema, Pericardial effusion, Generalised oedema, Arthritis infective, Bacterial abdominal infection, Hypersensitivity, |
||||
ALBUTEROL SULFATE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 550 | 26873566 |
US |
1 | |
Pruritus, Hypersensitivity, Product use issue, |
||||
FOSTAMATINIB, FOSTAMATINIB, AMITRIPTYLINE HYDROCHLORIDE, |
||||
| 551 | 26873761 |
US |
2 | |
Migraine, Hypersensitivity, Product dose omission issue, Dyspnoea, Hepatic enzyme increased, |
||||
FOSTAMATINIB, SULFASALAZINE, AZATHIOPRINE, AZATHIOPRINE, PREDNISONE, |
||||
| 552 | 26873972 |
US |
53 | 2 |
Nausea, Hypersensitivity, Headache, Heart rate increased, |
||||
DUPILUMAB, |
||||
| 553 | 26874114 |
US |
2 | |
Asthma, Hypersensitivity, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONAZEPAM, DIVALPROEX SODIUM, ROSUVASTATIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 554 | 26874350 |
US |
62 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 555 | 26874576 |
US |
2 | |
Hypersensitivity, |
||||
FOSTAMATINIB, |
||||
| 556 | 26874899 |
US |
48 | 1 |
Hypersensitivity, Cough, Rhinorrhoea, Pyrexia, |
||||
FOSTAMATINIB, |
||||
| 557 | 26875045 |
US |
65 | 2 |
Flushing, Paraesthesia, Product use in unapproved indication, Hypersensitivity, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 558 | 26868138 |
BR |
43 | 2 |
Dyspnoea, Hypersensitivity, Oedema, Product use in unapproved indication, |
||||
ETONOGESTREL AND ETHINYL ESTRADIOL, |
||||
| 559 | 26868929 |
US |
68 | |
Productive cough, Hypersensitivity, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, SELEXIPAG, MELOXICAM, NIFEDIPINE, ESTRADIOL VALERATE, KETOROLAC TROMETHAMINE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE TABLETS 250 MG, TIZANIDINE HYDROCHLORIDE, BACLOFEN, MEMANTINE, MEMANTINE HYDROCHLORIDE, ALBUTEROL SULFATE, CINNAMON, TADALAFIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, CARBOXYMETHYLCELLULOSE SODIUM, PREGABALIN, OXYGEN, 0XYGEN, CETIRIZINE HCL, CETIRIZINE, TIOTROPIUM BROMIDE AND OLODATEROL, |
||||
| 560 | 26869027 |
IN |
63 | |
Death, Hypersensitivity, Adverse event, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 561 | 26869093 |
US |
69 | 2 |
Hypersensitivity, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 562 | 26869410 |
CN |
9 | 2 |
Shock, Dyspnoea, Cyanosis, Blood pressure decreased, Pallor, Nausea, Dizziness, Hypersensitivity, |
||||
DUPILUMAB, EPINEPHRINE, ADRENALINUM, |
||||
| 563 | 26869638 |
US |
2 | |
Hypersensitivity, Swelling, |
||||
FAMOTIDINE, FAMOTIDINE TABLET, FILM-COATED, |
||||
| 564 | 26869761 |
US |
1 | |
Haematochezia, Hypersensitivity, Impaired healing, Wound, |
||||
SELUMETINIB, |
||||
| 565 | 26869868 |
US |
57 | |
Hypersensitivity, |
||||
CYCLOBENZAPRINE HYDROCHLORIDE, ALPRAZOLAM, ROSUVASTATIN, MELOXICAM, HYDROQUINONE, |
||||
| 566 | 26869913 |
US |
48 | 2 |
Vision blurred, Weight increased, Dizziness, Headache, Ocular stroke, Malaise, Pruritus, Urticaria, Menopause, Feeling abnormal, Retinal haemorrhage, Weight decreased, Hypersensitivity, |
||||
RANIBIZUMAB, BEVACIZUMAB, ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS), PROGESTERONE, |
||||
| 567 | 26869963 |
|||
Hypersensitivity, |
||||
ERTAPENEM, ERTAPENEM SODIUM, |
||||
| 568 | 26870191 |
US |
2 | |
Feeling hot, Heart rate increased, Pruritus, Hypersensitivity, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE, |
||||
| 569 | 26870534 |
US |
62 | |
Asthenia, Nasopharyngitis, Product dose omission issue, Illness, Alopecia, Sinus disorder, Fatigue, Headache, Hypotension, Hypersensitivity, Diarrhoea, Epistaxis, |
||||
TREPROSTINIL, TREPROSTINIL, METHOCARBAMOL, METHOCARBAMOL TABLETS, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE, THYROID, PORCINE, FUROSEMIDE, SILDENAFIL CITRATE, SILDENAFIL, HYDROXYCHLOROQUINE SULFATE, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MACITENTAN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, OXYGEN, 0XYGEN, |
||||
| 570 | 26870753 |
US |
80 | |
Cough, Hypersensitivity, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ALLOPURINOL, EMPAGLIFLOZIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, GABAPENTIN, EZETIMIBE, NINTEDANIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NITROGLYCERIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LISINOPRIL, SPIRONOLACTONE, OXYGEN, 0XYGEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PRIMIDONE, TORSEMIDE, |
||||
| 571 | 26870862 |
US |
62 | 2 |
Hypersensitivity, Dyspnoea, Productive cough, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 572 | 26870863 |
US |
39 | 2 |
Dyspnoea, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 573 | 26871073 |
67 | 2 | |
Hypersensitivity, Ocular hyperaemia, Eye swelling, Eye pruritus, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 574 | 26871256 |
US |
||
Skin exfoliation, Hypersensitivity, Onycholysis, |
||||
| 575 | 26871305 |
US |
59 | 1 |
Hypersensitivity, Burning sensation, |
||||
DUPILUMAB, |
||||
| 576 | 26871451 |
CN |
51 | 1 |
Hypersensitivity, Urticaria, Pruritus, Scratch, Skin wound, Laryngeal discomfort, Rash, Prescribed underdose, |
||||
EZETIMIBE, ROSUVASTATIN CALCIUM, |
||||
| 577 | 26871518 |
TW |
78 | 2 |
Hypersensitivity, Urticaria, Rash, Pruritus, Swelling of eyelid, Oedema peripheral, |
||||
LANSOPRAZOLE, |
||||
| 578 | 26871571 |
US |
41 | 2 |
Feeling hot, Skin discolouration, Alopecia, Feeling of body temperature change, Hypersensitivity, Dyspnoea, Condition aggravated, |
||||
AVAPRITINIB, |
||||
| 579 | 26871590 |
US |
48 | 2 |
Blood pressure increased, Hypersensitivity, |
||||
NATALIZUMAB, |
||||
| 580 | 26871664 |
CA |
73 | |
Urticaria, Fibromyalgia, Balance disorder, Gait disturbance, Hypersensitivity, Inappropriate schedule of product administration, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB-STBA, |
||||
| 581 | 26871697 |
US |
2 | |
Hypersensitivity, Drug effect less than expected, |
||||
BELIMUMAB, |
||||
| 582 | 26871709 |
US |
55 | 2 |
Swelling face, Hypersensitivity, Erythema, Off label use, |
||||
ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, |
||||
| 583 | 26872112 |
EU |
46 | 2 |
Injection site bruising, Rash macular, Hypersensitivity, Prescribed underdose, |
||||
POLIDOCANOL, POLIDOCANOL, |
||||
| 584 | 26872136 |
MX |
77 | 2 |
Factor XII deficiency, Bone demineralisation, Hypersensitivity, Chondropathy, |
||||
DENOSUMAB, |
||||
| 585 | 26872177 |
US |
48 | 2 |
Hypersensitivity, Product adhesion issue, |
||||
ESTRADIOL, ESTRADIOL, |
||||
| 586 | 26872180 |
25 | 2 | |
Hypersensitivity, |
||||
CEPHALEXIN, |
||||
| 587 | 26872241 |
CA |
59 | 2 |
Rash, Alopecia, Arthralgia, Arthropathy, Blister, Blood cholesterol increased, Diarrhoea, Discomfort, Duodenal ulcer perforation, Fatigue, Fibromyalgia, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Injury, Joint swelling, Malaise, Pericarditis, Pemphigus, Anxiety, Asthma, Decreased appetite, Lupus vulgaris, Retinitis, Rheumatic fever, Dizziness, Drug hypersensitivity, Ear infection, Foot deformity, Hepatic cirrhosis, Infection, Laryngitis, Osteoporosis, Pneumonia, Wound, |
||||
CYCLOSPORINE, DICLOFENAC, DICLOFENAC SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, AMLODIPINE, AMLODIPINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, USTEKINUMAB, USTEKINUMAB, SARILUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CALCIUM CARBONATE, ANTACID, AZATHIOPRINE, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, LORAZEPAM, LORAZEPAM, RAMIPRIL, RAMIPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 588 | 26872332 |
US |
63 | 2 |
Injection site rash, Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 589 | 26872383 |
US |
2 | |
Choking, Aphasia, Laryngospasm, Hypersensitivity, Swollen tongue, |
||||
ECULIZUMAB, |
||||
| 590 | 26872412 |
US |
74 | 2 |
Hypersensitivity, Eye swelling, Eye irritation, Eye irritation, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 591 | 26872449 |
US |
42 | 2 |
Influenza, Hypersensitivity, Dizziness, |
||||
| 592 | 26872571 |
76 | 1 | |
Eye pruritus, Pruritus, Hypersensitivity, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 593 | 26872651 |
2 | ||
Lung disorder, Enteritis, Anaesthetic complication, Hypersensitivity, |
||||
MACITENTAN, TREPROSTINIL, |
||||
| 594 | 26872813 |
US |
42 | 2 |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 595 | 26872842 |
71 | 2 | |
Blepharospasm, Eye movement disorder, Hypersensitivity, Eye pain, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 596 | 26872847 |
67 | 2 | |
Hypersensitivity, Eye irritation, Vision blurred, Palpitations, Dizziness, Nausea, Chest discomfort, Foreign body sensation in eyes, Abnormal sensation in eye, Pruritus, Eye pruritus, Dyspnoea, Nasal inflammation, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 597 | 26878348 |
2 | ||
Fluid retention, Localised oedema, Swelling face, Paraesthesia, Blood pressure decreased, Hypersensitivity, Product label issue, |
||||
| 598 | 26862668 |
US |
79 | 2 |
Hypersensitivity, |
||||
INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 599 | 26862791 |
EU |
11 | 2 |
Urticaria, Hypotension, Bradycardia, Cardiac arrest, Loss of consciousness, Hypersensitivity, Transfusion-related circulatory overload, Rash, Vomiting, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, BOSENTAN, LANSOPRAZOLE, EPOPROSTENOL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 600 | 26862957 |
PA |
72 | 2 |
Metastases to lung, Pulmonary oedema, Pulmonary thrombosis, Cough, Gait disturbance, Joint swelling, Osteoporosis, Cholelithiasis, Hypersensitivity, Nasopharyngitis, Headache, Pruritus, Scratch, Constipation, Vomiting, Discomfort, Movement disorder, Skin discolouration, Alopecia, Skin lesion, Lung disorder, Back pain, Condition aggravated, Malaise, Pleural disorder, Dyspepsia, Pallor, Cold sweat, Agitation, Fatigue, Respiratory rate decreased, Pain in extremity, Peripheral swelling, Pulmonary mass, Lethargy, Somnolence, Pyrexia, Chills, Rhinorrhoea, Productive cough, |
||||
FULVESTRANT, RIBOCICLIB, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, IRBESARTAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30